Skip to main content

Siena Biotech Buys More Licenses to GeneGo's MetaCore

NEW YORK (GenomeWeb News) - GeneGo said today that Siena Biotech has expanded its collection of MetaCore licenses by an undisclosed amount.
 
Siena is using the MetaCore technology to integrate multiple data types including proteomics and chemogenomics information.
 
Financial terms were not disclosed.
 
Other customers have recently extended their licenses with GeneGo, such as NHLBI in June and Merck in January.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.